RGEN today
$166.81+$0.29 (+0.17%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourExpanding
1 hourBearish
15 minBearish
5 minConsolidating
Daily trend turns down below $161.14
Key levels
Resistance$181.01
Resistance$168.03
Support$157.44
Support$144.65
Latest news & SEC filings
SEC FilingRepligen Corp filed a report on a major company event (Form 8-K)
NewsRepligen Says Filtration Unit Growth Outlook Is Positive, Per RBC
All RGEN news →About Repligen
Repligen supplies bioprocessing equipment and consumables used to make biologic medicines. Its offerings span four areas: filtration, chromatography, process analytics, and proteins, covering cell retention systems, pre-packed columns, spectroscopy instruments, and affinity ligands. Buyers include large drugmakers, contract manufacturers, and other firms in the biotech sector. The company runs manufacturing and office locations across North America, Europe, and Asia.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
REPLIGEN CORP (RGEN)
What Is the Price Target for RGEN?
SEPT Low Target
$136.00
SEPT Mid Target
$160.00
SEPT High Target
$184.00
Analyst Consensus
$160.00
Is RGEN a Buy or Sell Right Now?
Thesis
- •Revenue growing 16.4% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for RGEN.
Start Free Trial →Is RGEN Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$144.16
38
Moat Score
NONE
6/9
Piotroski Score
0.9
Altman Z-Score
What Is Smart Money Doing with RGEN?
Insider Signal
SELLING
0 buys / 4 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Douglass Brian Robb | officer | Buy | 700 | - | Oct 6, 2026 |
| Loeillot Olivier | director officer | Sale | 1,333 | $238K | Oct 5, 2026 |
| Loeillot Olivier | director officer | Buy | 4,202 | $651K | Oct 5, 2026 |
| Loeillot Olivier | director officer | Sale | 4,202 | $798K | Oct 5, 2026 |
| Loeillot Olivier | director officer | Sale | 1,248 | $227K | Oct 2, 2026 |
| Garland Jason K | officer | Sale | 421 | $80K | Sep 25, 2026 |
| Loeillot Olivier | director officer | Buy | 8,404 | $1.3M | Sep 24, 2026 |
| Loeillot Olivier | director officer | Sale | 8,404 | $1.6M | Sep 24, 2026 |
| Loeillot Olivier | director officer | Buy | 4,542 | $706K | Sep 24, 2026 |
| Loeillot Olivier | director officer | Sale | 4,542 | $863K | Sep 24, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →RGEN Growth Story
Revenue YoY
16.4%
3yr Revenue CAGR
-2.7%
EPS Growth YoY
286.96%
FCF Growth YoY
-37.3%
Revenue Trend
ACCELERATING
Dark Pool Trades for RGEN
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for RGEN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 15:22:50 | $166.16 | 1,600 | $$266K | MIDPOINT |
| 15:10:44 | $166.55 | 1,300 | $$217K | SELL |
| 21:28:31 | $166.59 | 6,700 | $$1.1M | SELL |
| 21:27:07 | $166.52 | 31,506 | $$5.2M | SELL |
| 21:00:25 | $166.52 | 2,344 | $$390K | SELL |
5 dark pool trades shown · $$7.2M preview volume
Real-time institutional flow, block trades, and net positioning
What Traders Are Saying About RGEN
1 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for RGEN. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Zone Setup -- $RGEN (REPLIGEN CORP) Price: $142.40 | Zone: $140.44 to $149.05 Conviction: HIGH | Analyst upside: +3.7% Near support (23% of range) — reversal watch. Strong positive news (2+ vs 0-)
Join 3,500+ traders discussing RGEN in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for REPLIGEN CORP (RGEN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →RGEN — frequently asked questions
What is RGEN stock price today?
REPLIGEN CORP (RGEN) is at $166.81, up 0.17% (+$0.29) at the Nov 13, 2026 close.
Why is RGEN stock moving today?
Latest RGEN news — Nov 6, 2026: Repligen Corp filed a report on a major company event (Form 8-K) · Nov 2, 2026: Repligen Says Filtration Unit Growth Outlook Is Positive, Per RBC
What is the RGEN price target?
The average analyst price target for RGEN is $160.00, ranging from $140 to $225, based on 8 analysts. Latest: UBS maintains on Sep 9, 2026.
What do analysts rate RGEN?
Analyst ratings for RGEN: 1 Buy, 8 Hold, 0 Sell — consensus Hold.
Did RGEN beat earnings?
RGEN last reported on Jul 28, 2026: EPS $2.03 vs $0.45 expected — a beat of 351.1%.
What is RGEN's P/E ratio?
RGEN trades at a P/E of 211.3.
Does RGEN pay a dividend?
RGEN does not currently pay a dividend.
How much debt does RGEN have?
REPLIGEN CORP reported $551M of debt and $607M of cash (Jun 30, 2026).
What are RGEN support and resistance levels?
Support: $157.44, $144.65, $130.03. Resistance: $168.03, $181.01, $191.05.
What are insiders doing with RGEN?
Insider activity: SELLING, 0 buys and 4 sells in the last 90 days.
What is the latest news on RGEN?
Nov 6, 2026: Repligen Corp filed a report on a major company event (Form 8-K) · Nov 2, 2026: Repligen Says Filtration Unit Growth Outlook Is Positive, Per RBC